Principal Financial Group Inc. increased its position in Signify Health, Inc. (NYSE:SGFY – Get Rating) by 38.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,301,297 shares of the company’s stock after purchasing an additional 362,380 shares during the quarter. Principal Financial Group Inc.’s holdings in Signify Health were worth $17,958,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in Signify Health in the first quarter worth about $28,000. Manchester Capital Management LLC acquired a new stake in Signify Health in the first quarter worth about $30,000. Advisor Group Holdings Inc. increased its position in Signify Health by 293.9% in the first quarter. Advisor Group Holdings Inc. now owns 2,198 shares of the company’s stock worth $40,000 after purchasing an additional 1,640 shares during the period. Federated Hermes Inc. bought a new position in Signify Health during the first quarter worth about $42,000. Finally, Quantamental Technologies LLC bought a new position in Signify Health during the first quarter worth about $185,000. 90.07% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
SGFY has been the topic of a number of recent analyst reports. Truist Financial initiated coverage on Signify Health in a report on Wednesday, September 7th. They set a “hold” rating and a $30.50 target price on the stock. JPMorgan Chase & Co. cut Signify Health from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $32.00 to $30.50 in a report on Tuesday, September 6th. UBS Group cut Signify Health from a “buy” rating to a “neutral” rating and raised their target price for the stock from $27.00 to $30.50 in a report on Wednesday, September 7th. Piper Sandler cut Signify Health from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $34.00 to $30.50 in a report on Tuesday, September 6th. Finally, Barclays raised their target price on Signify Health to $21.00 in a report on Monday, August 15th. Ten investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Signify Health has a consensus rating of “Hold” and a consensus price target of $28.15.
Signify Health Stock Performance
About Signify Health
Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.
- Get a free copy of the StockNews.com research report on Signify Health (SGFY)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Signify Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health and related companies with MarketBeat.com's FREE daily email newsletter.